Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q4 FY2025 (2025-12-31): -70.21.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-446.18
EARNINGS PER SHARE (EPS) AVG 3Y
-284.47
EARNINGS PER SHARE (EPS) AVG 5Y
-299.57
EARNINGS PER SHARE (EPS) AVG 10Y
-163.40
EARNINGS PER SHARE (EPS) AVG 15Y
-51.84
EARNINGS PER SHARE (EPS) AVG 20Y
-97.51
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SciSparc Ltd.
Market Cap
$246973.00
Earnings Per Share (EPS)
N/A
TTM Avg
-446.18
3Y Avg
-284.47
5Y Avg
-299.57
Market Cap
$363900.00
Earnings Per Share (EPS)
N/A
TTM Avg
-30.82
3Y Avg
-68.47
5Y Avg
-54.27
Market Cap
$109693.00
Earnings Per Share (EPS)
-56.54
TTM Avg
-2021.61
3Y Avg
-2656.46
5Y Avg
-1785.38
Market Cap
$97282.00
Earnings Per Share (EPS)
N/A
TTM Avg
-5.39
3Y Avg
-4.78
5Y Avg
-3.78
Market Cap
$403887.00
Earnings Per Share (EPS)
N/A
TTM Avg
-48.50
3Y Avg
-108.50
5Y Avg
-157.67
Market Cap
$70876.00
Earnings Per Share (EPS)
-11.16
TTM Avg
-405.74
3Y Avg
-2510.68
5Y Avg
-2758.31
Market Cap
$60201.00
Earnings Per Share (EPS)
N/A
TTM Avg
-459.91
3Y Avg
-720819.96
5Y Avg
-483554.38
Market Cap
$30997.00
Earnings Per Share (EPS)
N/A
TTM Avg
-130.67
3Y Avg
-1084.61
5Y Avg
-489.21
Market Cap
$29279.00
Earnings Per Share (EPS)
N/A
TTM Avg
-110.58
3Y Avg
-60.80
5Y Avg
-49.51
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SciSparc Ltd. (SPRC) | $246973.00 | N/A | -446.18 | -284.47 | -299.57 |
| Virax Biolabs Group Limited (VRAX)vs › | $363900.00 | N/A | -30.82 | -68.47 | -54.27 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109693.00 | -56.54 | -2021.61 | -2656.46 | -1785.38 |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | N/A | -5.39 | -4.78 | -3.78 |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | N/A | -48.50 | -108.50 | -157.67 |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | -11.16 | -405.74 | -2510.68 | -2758.31 |
| Akanda Corp. (AKAN)vs › | $60201.00 | N/A | -459.91 | -720819.96 | -483554.38 |
| Zhongchao Inc. (ZCMD)vs › | $30997.00 | N/A | -130.67 | -1084.61 | -489.21 |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29279.00 | N/A | -110.58 | -60.80 | -49.51 |
| XORTX Therapeutics Inc. (XRTX)vs › | $484571.00 | -2.74 | -4.14 | -35.99 | -26.33 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -882.64 |
| 2024-12-31 | -9.72 |
| 2023-12-31 | -112.95 |
| 2022-12-31 | -132.57 |
| 2021-12-31 | -659.52 |
| 2020-12-31 | 0.00 |
| 2019-12-31 | 0.00 |
| 2018-12-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2013-12-31 | 0.00 |
| 2012-12-31 | -7.47 |
| 2011-12-31 | -217.62 |
| 2010-12-31 | -245.43 |
| 2009-12-31 | -189.36 |
| 2008-12-31 | -275.67 |
| 2007-12-31 | -414.00 |
| 2006-12-31 | -150.39 |
